Clinical trials
Phase 2 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
560 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 14 |
| 2005 | 15 |
| 2006 | 22 |
| 2007 | 18 |
| 2008 | 26 |
| 2009 | 35 |
| 2010 | 15 |
| 2011 | 30 |
| 2012 | 28 |
| 2013 | 10 |
| 2014 | 16 |
| 2015 | 22 |
| 2016 | 20 |
| 2017 | 23 |
| 2018 | 33 |
| 2019 | 23 |
| 2020 | 20 |
| 2021 | 26 |
| 2022 | 28 |
| 2023 | 25 |
| 2024 | 30 |
| 2025 | 31 |
| 2026 | 24 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 334 |
| Terminated | 69 |
| Recruiting | 54 |
| Unknown status | 40 |
| Active, not recruiting | 22 |
| Not yet recruiting | 18 |
| Withdrawn | 16 |
| Enrolling by invitation | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 19 |
| Eli Lilly and Company | 13 |
| GlaxoSmithKline | 11 |
| Avid Radiopharmaceuticals | 10 |
| Chang Gung Memorial Hospital | 10 |
| Merck Sharp & Dohme LLC | 8 |
| AbbVie (prior sponsor, Abbott) | 7 |
| Boehringer Ingelheim | 6 |
| Genentech, Inc. | 6 |
| Hoffmann-La Roche | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 560 |
| Cognitive Dysfunction | 125 |
| Dementia | 102 |
| Neurodegenerative Diseases | 28 |
| Central Nervous System Diseases | 21 |
| Brain Diseases | 20 |
| Memory Disorders | 20 |
| Nervous System Diseases | 16 |
| Mental Disorders | 15 |
| Tauopathies | 15 |
Trials
Showing 51 to 75 of 560. Each trial links to its page on Pharma Observatory.
460 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.